In human pancreatic cancer, the PI3K/Akt/mTOR pathway is deregulated in the majority of tumors11, 12, 13, and the activation of this pathway correlates significantly with a poor prognosis14. This evidence concerns the gene MTOR and pancreatic neoplasm.